Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 22, 1998

View Archived Issues

Innovative Therapies for Rheumatoid Arthritis

Pivotal Zadaxin trial to begin in Japan

Connetics completes phase I/II MS trial; European patent granted

Targon and Duke University form oncology alliance

Timentin cleared for pediatric use in U.S.

Hydroxamic acid-based inhibitors of TNF and/or MMPs under study at Zeneca

Merck & Co.'s new HIV protease inhibitors

Pfizer presents new serotonergic agents

Inhibitors of COX-1/COX-2 from Roche

New cephems described by Fujisawa

Japan Energy describes inhibitors of SMC proliferation

New 5-HT1B antagonists developed at SmithKline Beecham

Yamasa presents novel xanthine oxidase inhibitors

Korean researchers characterize new antimicrobial/cytotoxic compound of microbial origin

Repligen and Glaxo extend Glyceptor collaboration

T Cell Sciences and Walter Reed collaborate on inhibition of liposome-induced complement activation

Dexketoprofen trometamol approved in E.U. countries

Botox compared to saline for chronic anal fissure

HMR and Abbott sign marketing agreement for Anzemet

Gastrimmune significantly increases survival in advanced colorectal cancer

Genetronics to begin phase II head and neck cancer trial in Canada

Commencement of Ossigel clinical trials

Connetics amends payment terms, sells Canadian rights to Ridaura

HMR and Allelix end collaboration for treatment of schizophrenia

Searle and Yamanouchi join forces in broad research alliance

Titan reports results from preclinical Parkinson's trial

Streptogramins in the treatment of drug-resistant infections

New HIV-based gene delivery system pioneered at Oxford BioMedica

FDA accepts RenaGel NDA for filing

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...